Paper
11 September 2006 Early panretinal photocoagulation for the treatment of ischemic central retinal vein occlusion
Zikui Yu, Naizhen He
Author Affiliations +
Proceedings Volume 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery; 59671M (2006) https://doi.org/10.1117/12.639341
Event: 2004 Shanghai international Conference on Laser Medicine and Surgery, 2004, Shanghai, China
Abstract
Objective: To evaluate the safety and efficacy of treating ischemic central retinal vein occlusion (CRVO) with early panretinal photocoagulation (PRP). Methods: 24 eyes of 24 cases suffered from ischemic CRVO with history shorter than 3 months were included in this study. PRP treatments were completed through 3 to 5 times of laser therapy with total laser burns of 1000 to 2000 (mean 1505±384). Patients were followed up 3 months to 2 years, mean 18.4±8.0 months. The neovascularization regression and visual acuity were compared before and after PRP, also the long-term complications were observed. Results: 3 eyes of iris neovascularization (INV) regressed after PRP and there was no significant difference in visual acuity between prelaser and postlaser. No neovascular glaucoma (NVG) occurred and 2 eyes occurred vitreous hemorrhage during the follow up period. Conclusions: Early panretinal photocoagulation is safe and efficacious in preventing and reducing complications of ischemic CRVO. It can save valuable treatment time for some patients.
© (2006) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Zikui Yu and Naizhen He "Early panretinal photocoagulation for the treatment of ischemic central retinal vein occlusion", Proc. SPIE 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery, 59671M (11 September 2006); https://doi.org/10.1117/12.639341
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Laser therapeutics

Veins

Visualization

Laser coagulation

Vitreous

Eye

Iris

RELATED CONTENT


Back to Top